Dr. George Aaron DuVall
Claim this profileTyler Research Institute, LLC
Affiliated Hospitals
Tyler Research Institute, LLC
Digestive Health Specialists Of Tyler
Clinical Trials George Aaron DuVall is currently running
Obefazimod
for Crohn's Disease
This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared to placebo as induction and maintenance therapy in subjects with moderately to severely active CD after inadequate response (no response, loss of response, or intolerance) to conventional therapies and/or advanced therapies. The primary objective for the 48-Week Extension Phase is to evaluate the safety and tolerability of obefazimod compared with placebo in subjects who are enrolled in the Extension Phase.
Recruiting
0 awards
Phase 2
4 criteria
Vedolizumab + Adalimumab/Ustekinumab
for Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual targeted treatment. The study is conducted in two parts. In Part A, participants will receive the dual targeted treatment (vedolizumab together with either adalimumab or ustekinumab). In part B, participants will receive vedolizumab only. Part B will include participants who responded to the treatment in Part A. Each participant will be followed up for at least 26 weeks after the last dose of treatment.
Recruiting
3 awards
Phase 4
10 criteria
More about George Aaron DuVall
Clinical Trial Related
1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments George Aaron DuVall has experience with
- Mirikizumab
- Vedolizumab
- ABX464
- Tofacitinib
- Adalimumab
- Ustekinumab
Breakdown of trials George Aaron DuVall has run
Ulcerative Colitis
Crohn's Disease
Colitis
Crohn's disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does George Aaron DuVall specialize in?
George Aaron DuVall focuses on Ulcerative Colitis and Crohn's Disease. In particular, much of their work with Ulcerative Colitis has involved treating patients, or patients who are undergoing treatment.
Is George Aaron DuVall currently recruiting for clinical trials?
Yes, George Aaron DuVall is currently recruiting for 3 clinical trials in Tyler Texas. If you're interested in participating, you should apply.
Are there any treatments that George Aaron DuVall has studied deeply?
Yes, George Aaron DuVall has studied treatments such as Mirikizumab, Vedolizumab, ABX464.
What is the best way to schedule an appointment with George Aaron DuVall?
Apply for one of the trials that George Aaron DuVall is conducting.
What is the office address of George Aaron DuVall?
The office of George Aaron DuVall is located at: Tyler Research Institute, LLC, Tyler, Texas 75701 United States. This is the address for their practice at the Tyler Research Institute, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.